PapersFlow Research Brief
Lymphatic Disorders and Treatments
Research Guide
What is Lymphatic Disorders and Treatments?
Lymphatic disorders and treatments encompass the diagnosis and management of conditions such as chylothorax and chylous ascites, with a focus on the lymphatic system, thoracic duct, and strategies including lymphangiography and octreotide therapy, particularly in pediatric and surgical contexts.
The field addresses chylothorax, chylous ascites, and related lymphatic malformations through surgical and pharmacological interventions. There are 15,808 papers in this cluster. Growth over the past 5 years is not available.
Topic Hierarchy
Research Sub-Topics
Chylothorax Management
This sub-topic covers conservative treatments like dietary modification, TPN, and octreotide alongside surgical interventions such as thoracic duct ligation. Researchers compare outcomes in traumatic vs. non-traumatic etiologies.
Chylous Ascites Etiology and Treatment
Studies investigate postoperative, neoplastic, and cirrhotic causes with focus on peritoneal drainage and somatostatin analogs. Researchers assess diagnostic paracentesis and long-term resolution rates.
Lymphangiography in Lymphatic Disorders
This area evaluates intranodal and pedal lymphangiography for leak localization and therapeutic embolization. Researchers study contrast agents and imaging modalities for thoracic duct anatomy.
Pediatric Chylothorax
Researchers examine congenital lymphatic malformations, post-cardiac surgery cases, and medical management in neonates. Studies report survival predictors and conservative therapy success rates.
Thoracic Duct Injury and Repair
This sub-topic details iatrogenic injuries during esophagectomy and cardiothoracic procedures with microsurgical repair techniques. Researchers analyze fistula detection and prevention strategies.
Why It Matters
Management of chylothorax and chylous ascites prevents complications in pediatric and surgical patients by addressing thoracic duct disruptions and lymphatic leaks. McGrath et al. (2009) in "Chylothorax: Aetiology, diagnosis and therapeutic options" outline diagnostic and therapeutic approaches that reduce mortality in respiratory cases. Aalami et al. (2000) in "Chylous ascites: A collective review" detail 62 cases where conservative treatments succeeded in 56%, avoiding invasive surgery. Faul et al. (2000) in "Thoracic Lymphangiomas, Lymphangiectasis, Lymphangiomatosis, and Lymphatic Dysplasia Syndrome" describe rare thoracic lymphatic disorders requiring targeted interventions to manage respiratory failure.
Reading Guide
Where to Start
"Chylothorax: Aetiology, diagnosis and therapeutic options" by McGrath et al. (2009), as it provides a direct overview of clinical diagnosis and management strategies central to the topic.
Key Papers Explained
Schacht (2003) in "T1/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema" establishes podoplanin’s role in lymphatic development, which Schacht et al. (2005) in "Up-Regulation of the Lymphatic Marker Podoplanin, a Mucin-Type Transmembrane Glycoprotein, in Human Squamous Cell Carcinomas and Germ Cell Tumors" extends to cancer contexts. François et al. (2008) in "Sox18 induces development of the lymphatic vasculature in mice" complements this by detailing genetic induction of lymphatics. McGrath et al. (2009) in "Chylothorax: Aetiology, diagnosis and therapeutic options" and Aalami et al. (2000) in "Chylous ascites: A collective review" apply these insights to clinical chylothorax and ascites management. Faul et al. (2000) in "Thoracic Lymphangiomas, Lymphangiectasis, Lymphangiomatosis, and Lymphatic Dysplasia Syndrome" covers rare malformations.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research centers on refining lymphangiography and octreotide protocols for chylothorax, as no recent preprints or news are available. Focus persists on thoracic duct interventions in surgery.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | T1 /podoplanin deficiency disrupts normal lymphatic vasculatur... | 2003 | The EMBO Journal | 664 | ✓ |
| 2 | Peritioneal carcinomatosis in nongynecologic malignancy. A pro... | 1989 | Cancer | 595 | ✓ |
| 3 | Up-Regulation of the Lymphatic Marker Podoplanin, a Mucin-Type... | 2005 | American Journal Of Pa... | 595 | ✓ |
| 4 | Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Me... | 2004 | Journal of Biological ... | 579 | ✓ |
| 5 | Sox18 induces development of the lymphatic vasculature in mice | 2008 | Nature | 558 | ✕ |
| 6 | Pathogenesis of persistent lymphatic vessel hyperplasia in chr... | 2005 | Journal of Clinical In... | 543 | ✓ |
| 7 | Anatomie des lymphatiques de l'homme. | 1932 | Journal of the America... | 503 | ✕ |
| 8 | Chylothorax: Aetiology, diagnosis and therapeutic options | 2009 | Respiratory Medicine | 475 | ✕ |
| 9 | Chylous ascites: A collective review | 2000 | Surgery | 442 | ✕ |
| 10 | Thoracic Lymphangiomas, Lymphangiectasis, Lymphangiomatosis, a... | 2000 | American Journal of Re... | 409 | ✕ |
Frequently Asked Questions
What causes chylothorax?
Chylothorax results from thoracic duct injury or obstruction, leading to chyle accumulation in the pleural space. McGrath et al. (2009) in "Chylothorax: Aetiology, diagnosis and therapeutic options" identify trauma, surgery, and malignancy as primary etiologies. Therapeutic options include conservative management and surgical ligation.
How is chylous ascites managed?
Chylous ascites arises from lymphatic leakage into the peritoneum, often post-surgery or due to malignancy. Aalami et al. (2000) in "Chylous ascites: A collective review" report success with dietary fat restriction and octreotide in 56% of 62 cases. Surgical interventions like peritoneovenous shunts are used when conservative measures fail.
What role does podoplanin play in lymphatic disorders?
Podoplanin is a lymphatic marker whose deficiency disrupts vasculature formation, causing lymphedema. Schacht (2003) in "T1/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema" demonstrates failed lymphatic development in deficient mice. Its upregulation occurs in squamous cell carcinomas.
What are thoracic lymphangiomas?
Thoracic lymphangiomas involve lymphatic malformations causing lymphangiectasis and dysplasia syndrome. Faul et al. (2000) in "Thoracic Lymphangiomas, Lymphangiectasis, Lymphangiomatosis, and Lymphatic Dysplasia Syndrome" describe adult presentations with respiratory symptoms. Treatment includes sclerosis and resection.
How does Sox18 affect lymphatic development?
Sox18 transcription factor induces lymphatic vasculature formation. François et al. (2008) in "Sox18 induces development of the lymphatic vasculature in mice" show its necessity for endothelial specification. Mutations lead to lymphatic hypoplasia.
What is the current state of lymphatic disorder treatments?
Treatments emphasize conservative measures like octreotide and lymphangiography before surgery. The field has 15,808 papers, focusing on chylothorax and ascites management. No recent preprints or news indicate stable research without major shifts.
Open Research Questions
- ? How can podoplanin expression be targeted to restore lymphatic vasculature in lymphedema patients?
- ? What drives persistent lymphatic hyperplasia in chronic inflammation beyond VEGF signaling?
- ? Which surgical techniques best repair thoracic duct injuries in pediatric chylothorax?
- ? How does Sox18 interact with other factors in human lymphatic development?
- ? What prognostic factors predict response to octreotide in chylous ascites?
Recent Trends
The cluster holds 15,808 papers with no 5-year growth data available.
No preprints from the last 6 months or news from the last 12 months indicate steady focus on established topics like chylothorax management per McGrath et al. .
2009Research Lymphatic Disorders and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Lymphatic Disorders and Treatments with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers